With a new blood cancer diagnosis every 27 seconds worldwide, Cure Leukaemia funds research nurses and clinical roles at blood cancer centres across the UK, providing patients with access to innovative and potentially life-saving treatments through clinical trials. By supporting these roles, Cure Leukaemia facilitates potentially life-saving advancements in blood cancer therapies nationally but also contributes to global progress and hope for those impacted by the disease worldwide.

Through the TAP Network and ATICUS Paediatric Networks patients are connected with world-class and potentially lifesaving treatment that would otherwise not be available to them through standard care.